M. Shahidi

发表

Synthesis of bentonite-β-cyclodextrin-iron nanoparticles composite as a magnetic adsorbent in solid-phase extraction for separation of nicotinic acid N-methylbetaine: an optimized process

M. Kazemipour, M. Ansari, Mahdieh Abbasi Meymand, 2021, Polymer Bulletin.

LUX-Lung 3: A randomized, open-label, phase III study of afatinib versus pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations.

Chun-Ming Tsai, Dan Massey, Nobuyuki Yamamoto, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiovascular D isease a s a L ong-Term C omplication o f Treatment f or T esticular C ancer

A. Horwich, A. Norman, J. Nicholls, 2003 .

A phase II study of BIBW 2992, a novel irreversible dual EGFR and HER2 tyrosine kinase inhibitor (TKI), in patients with adenocarcinoma of the lung and activating EGFR mutations after failure of one line of chemotherapy (LUX-Lung 2).

J. Shih, V. Miller, Yuh-Min Chen, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)

T. Naito, T. Takahashi, H. Murakami, 2012, Cancer Chemotherapy and Pharmacology.

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials.

L. Sequist, K. O'Byrne, T. Mok, 2015, The Lancet. Oncology.

Use of BIBW 2992, a novel irreversible EGFR/HER2 TKI, to induce regression in patients with adenocarcinoma of the lung and activating EGFR mutations: Preliminary results of a single-arm phase II clinical trial

J. Shih, V. Miller, Chun-Ming Tsai, 2008 .

Late recurrence in 1263 men with testicular germ cell tumors

D. Dearnaley, A. Horwich, R. Huddart, 2002, Cancer.

A phase II study of BIBW 2992 in patients with adenocarcinoma of the lung and activating EGFR mutations (LUX-Lung 2).

J. Shih, S. Ou, V. Miller, 2010 .

Diethylstilbestrol in castration‐resistant prostate cancer

D. Dearnaley, A. Horwich, R. Huddart, 2012, BJU international.

Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers

T. Ebner, H. Narjes, P. Stopfer, 2012, Cancer Chemotherapy and Pharmacology.

PLS. plenary session

C. Obasaju, C. Gridelli, L. Sequist, 2012 .

L. Sequist, K. O'Byrne, T. Mok, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

9166 Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations

L. Decoster, E. Teugels, C. Geers, 2009 .

Heterotopic bone formation: irradiation of high risk patients.

J. Glees, M. Shahidi, P. Cornes, 2002, The British journal of radiology.

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial.

K. O'Byrne, Keunchil Park, T. Mok, 2016, The Lancet. Oncology.

Recovery of serum testosterone after neoadjuvant androgen deprivation therapy and radical radiotherapy in localized prostate cancer

D. Dearnaley, A. Horwich, R. Huddart, 2006, BJU international.

A phase II study of daily afatinib (BIBW 2992) with or without temozolomide (21/28 days) in the treatment of patients with recurrent glioblastoma.

W. Mason, D. Eisenstat, S. Phuphanich, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Corrosion Inhibition of Mild Steel in Acidic Solution by Apricot Gum as a Green Inhibitor

M. J. Bahrami, A. Mohammadi, M. Shahidi, 2016 .

Electrochemical evaluation of antibacterial drugs as environment-friendly inhibitors for corrosion of carbon steel in HCl solution

M. Shahidi, D. Ghazanfari, G. Golestani, 2014 .

Comparison of electrochemical current noise signals arising from symmetrical and asymmetrical electrodes made of Al alloys at different pH values using statistical and wavelet analysis. Part II: Alkaline solutions

M. J. Bahrami, M. Shahidi, S. Hosseini, 2014 .

Comparison of Symmetrical and Asymmetrical Cells by Statistical and Wavelet Analysis of Electrochemical Noise Data

S.M.A. Hosseini, Amir Homayoun Jafari, M. Shahidi, 2012 .

Experimental and theoretical investigation of clemastine drug for corrosion protection of carbon steel in sulfuric acid solution

M. Kazemipour, M. Shahidi, Roohangiz Morshedi, 2020 .

Electrodeposited polypyrrole coatings on mild steel: Modeling the EIS data with a new equivalent circuit and the influence of scan rate and cycle number on the corrosion protection

M. Shahidi, M. Foroughi, M. Shahidi, 2017 .

Investigating the Effect of Penicillin G as Environment-friendly Corrosion Inhibitor for Mild Steel in H3PO4 Solution

M. Shahidi, F. Soltaninejad, 2018 .

INVESTIGATION OF THE EFFECT OF VANILLIN AS A GREEN CORROSION INHIBITOR FOR STAINLESS STEEL USING ELECTROCHEMICAL TECHNIQUES

M. Shahidi, M. Ganjehkaviri, M. Gholamhosseinzadeh, 2012 .

Synthesis of bentonite-β-cyclodextrin-iron nanoparticles composite as a magnetic adsorbent in solid-phase extraction for separation of nicotinic acid N-methylbetaine: an optimized process

M. Kazemipour, M. Ansari, Mahdieh Abbasi Meymand, 2021, Polymer Bulletin.

Pulmonary calcification.

M. Shahidi, A. Alizadeh, 1976, Chest.

Sensitive determination of hydroxylamine by using modified electrode by La2O3–Co3O4 nanocomposite and ionic liquid

S. Mohammadi, M. Shahidi, H. Asadollahzadeh, 2022, Materials Chemistry and Physics.

An electrochemical nano-sensor for determination of hydrazine using modified electrode by La2O3–Co3O4 nanohybrids and ionic liquid

S. Mohammadi, M. Shahidi, H. Asadollahzadeh, 2021, Journal of Materials Science: Materials in Electronics.

Electrochemical determination of 6-Tioguanine by using modified screen-printed electrode: magnetic core–shell Fe3O4@SiO2/MWCNT nanoparticles

S. Mohammadi, M. Shahidi, H. Asadollahzadeh, 2023, Journal of the Iranian Chemical Society.

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

Chun-Ming Tsai, Dan Massey, Nobuyuki Yamamoto, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Investigation of the cathodic process influence on the electrochemical noise signals arising from pitting corrosion of Al alloys using wavelet analysis

M. Shahidi, S. Hosseini, M. Gholamhosseinzadeh, 2013 .

Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors.

R. Plummer, A. Futreal, M. Uttenreuther-Fischer, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations.

L. Sequist, K. O'Byrne, T. Mok, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial.

J. Shih, L. Sequist, S. Ou, 2012, The Lancet. Oncology.

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.

Yan Sun, Lucio Crino, Xiuyu Julie Cong, 2012, The Lancet. Oncology.

A phase I study of daily BIBW 2992, an irreversible EGFR/HER-2 dual kinase inhibitor, in combination with weekly paclitaxel.

J. Spicer, S. Rudman, J. D. de Bono, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.

Y. Ichinose, K. Kiura, K. Goto, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The impact of metastasis tumour supressor-1 (MTSS1) on the metastatic characteristics of non small cell lung cancer and its association with smoking history [Abstract]

V. Miller, A. Dudek, M. Shahidi, 2009 .

Modified electrode by using magnetic core–shell Fe3O4@SiO2/MWCNT nanoparticles for determination of 6-mercaptopurine

M. Shahidi, H. Asadollahzadeh, M. Ghazizadeh, 2023, Journal of Materials Science: Materials in Electronics.

Electrochemical fabrication of polypyrrole/hazelnut shells modified carbon nanocomposite sorbent for determination of polycyclic aromatic hydrocarbons using headspace solid-phase microextraction-gas chromatography

M. Kazemipour, M. Ansari, M. Shahidi, 2021, Green Chemistry Letters and Reviews.

Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer.

D. Dearnaley, A. Horwich, R. Huddart, 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

Activity and tolerability of afatinib (BIBW 2992) and cetuximab in NSCLC patients with acquired resistance to erlotinib or gefitinib.

H. Groen, W. Pao, E. Smit, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cardiovascular disease as a long-term complication of treatment for testicular cancer.

D P Dearnaley, D. Dearnaley, A. Horwich, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes.

R. Kaiser, M. Eichelbaum, H. Varker, 2011, Lung cancer.

A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).

Y. Ichinose, H. Saka, K. Kiura, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Electrochemical Evaluation of Polyvinyl Butyral Coating Containing Polypyrrole/ZnO Nanocomposite for Corrosion protection of Al Alloy

M. J. Bahrami, M. Shahidi, S. Hosseini, 2017 .

D7-02: Activity of BIBW2992, an oral irreversible dual EGFR/HER2 inhibitor, in non-small cell lung cancer (NSCLC) with mutated EGFR

R. Plummer, A. Futreal, J. Spicer, 2007 .

Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.

M. Stolte, A. Mohamadkhani, M. Shahidi, 2012, Archives of Iranian medicine.

Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease.

A. Horwich, D. Cunningham, M. Shahidi, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Pharmacokinetics (PK) of [14C]-BIBW 2992 after administration of a single dose of 15 mg [14C]-BIBW 2992 oral solution in healthy male volunteers

B. Gaschler-Markefski, H. Narjes, P. Stopfer, 2008 .

LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.

Y. Ichinose, K. Kiura, K. Goto, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity of BIBW 2992, an oral irreversible EGFR/HER2 dual kinase inhibitor, in combination with weekly paclitaxel in non-small cell lung cancer

M. Uttenreuther-Fischer, J. Spicer, S. Rudman, 2009 .

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations

Jie Yang, L. Sequist, K. O'Byrne, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Addition of 18F-FDG-PET scans to radiotherapy planning of thoracic lymphoma.

S. Webb, C. Rowbottom, G. Cook, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Electrochemical and Quantum Chemical Study of Vanillin as a Green Corrosion Inhibitor for AA6061 in NaCl Solution

M. J. Bahrami, M. Shahidi, R. Mansouri, 2015 .